{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-22-014884","form_type":"8-K","ticker":"OMER","cik":"0001285819","company_name":"OMEROS CORP","filed_at":"2022-10-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.003937+00:00","generated_at":"2026-06-23T04:56:18.595307+00:00","sec_items":["1.01","2.03"],"event_type":"debt","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Omeros sells portion of OMIDRIA royalties for $125M; total capped payments of $188.4M through 2030","bullets":["Received $125M upfront from DRI Healthcare for partial sale of OMIDRIA royalties.","DRI gets capped payments: $1.67M in 2022, $13M in 2023, $20M in 2024, $25M/yr 2025-28, $26.25M 2029, $27.5M 2030.","Total payments to DRI capped at $188.4M; Omeros retains royalties above annual caps.","No recourse to Omeros assets beyond purchased receivables; no financial covenants.","Agreement terminates Dec 31, 2030 or when DRI receives all payments due."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-22-014884","json":"https://secwatch.observer/filing/0001558370-22-014884.json","markdown":"https://secwatch.observer/filing/0001558370-22-014884.md","text":"https://secwatch.observer/filing/0001558370-22-014884.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1285819/000155837022014884/0001558370-22-014884-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1285819/000155837022014884/omer-20220930x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T04:56:18.595307+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}